CALCICO THERAPEUTICS

Calcico is a venture backed biotechnology company focused on the development of novel CRAC channel inhibitors. The company aims to develop selective small molecules to treat a range of inflammatory and autoimmune conditions where there is clear evidence linking CRAC to human disease. Calcico is an Oxford based start up which was formed in April 2012 and funded by Advent Life Sciences and Touchstone Innovations. The company has developed proprietary ‘know-how’ comprising novel systems for selective CRAC channel screening and molecule characterisation. This puts us in a unique position to achieve the goal of potent and selective CRAC channel inhibition, which has so far eluded pharmaceutical companies.

#People #Financial #Website #More

CALCICO THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Life Science

Founded:

2012-01-01

Address:

Oxford, Oxfordshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.calcico.com

Total Employee:

1+

Status:

Closed

Contact:

+44 (0)1865 784794

Email Addresses:

[email protected]

Total Funding:

0

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema

Current Employees Featured

fraser-murray_image

Fraser Murray
Fraser Murray Vice President of Biology @ Calcico Therapeutics
Vice President of Biology

Investors List

advent-life_image

Advent Life Sciences

Advent Life Sciences investment in Venture Round - Calcico Therapeutics

Official Site Inspections

http://www.calcico.com

Host Informations
Whois Informations

Loading ...

More informations about "Calcico Therapeutics" on Search Engine